Seeking Alpha

Insys Therapeutics beats by $0.07, beats on revenue

  • Insys Therapeutics (INSY): Q4 EPS of $0.71 beats by $0.07.
  • Revenue of $40.2M beats by $5.47M.
  • Press Release
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: